학술논문
662 - The anti-leukemic drug nilotinib inhibits metastatic properties of colorectal cancer cells by targeting the receptor tyrosine kinase DDR1
Document Type
Abstract
Author
Source
In European Journal of Cancer July 2016 61 Supplement 1:S148-S149
Subject
Language
ISSN
0959-8049